Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Author
Faustini, SianShields, Adrian
Banham, Gemma
Wall, Nadezhda
Al-Taei, Saly
Tanner, Chloe
Ahmed, Zahra
Efstathiou, Elena
Townsend, Neal
Goodall, Margaret
Plant, Tim
Perez-Toledo, Marisol
Jasiulewicz, Aleksandra
Price, Ruth
McLaughlin, James
Farnan, John
Moore, Julie
Robertson, Louise
Nesbit, Andrew
Curry, Grace
Black, Amy
Cunningham, Adam
Harper, Lorraine
Moore, Tara
Drayson, Mark
Richter, Alex
Publication date
2022-01-10Subject
Microbiology. Immunology
Metadata
Show full item recordAbstract
No abstract availableCitation
Faustini S, Shields A, Banham G, Wall N, Al-Taei S, Tanner C, Ahmed Z, Efstathiou E, Townsend N, Goodall M, Plant T, Perez-Toledo M, Jasiulewicz A, Price R, McLaughlin J, Farnan J, Moore J, Robertson L, Nesbit A, Curry G, Black A, Cunningham A, Harper L, Moore T, Drayson M, Richter A. Cross reactivity of spike glycoprotein induced antibody against Delta and Omicron variants before and after third SARS-CoV-2 vaccine dose in healthy and immunocompromised individuals. J Infect. 2022 Apr;84(4):579-613. doi: 10.1016/j.jinf.2022.01.002. Epub 2022 Jan 10Type
ArticleAdditional Links
http://www.sciencedirect.com/science/journal/01634453PMID
35016901Journal
Journal of InfectionPublisher
W.B. Saundersae974a485f413a2113503eed53cd6c53
10.1016/j.jinf.2022.01.002